2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
3
Prostatic Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Spinal Fractures
1
Radiation Injuries
1
Primary Myelofibrosis
1
Polyps
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Osteoporosis
1
Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid
1
Heart Diseases
1
Gingivitis
1
Focal Liver Lesions
1
Disease
1
Colorectal Neoplasms
1
Colonic Polyps
1
Colonic Neoplasms
1
Colonic Diseases
1
Colitis
1
Childhood Brain Neoplasm
1
Atrial Fibrillation
1
Arrhythmias, Cardiac
1
Interventions
Blood Specimen Collection
9
Surveys and Questionnaires
6
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Prednisone
5
Mammography
5
Colonoscopy
5
Biopsy
5
Positron Emission Tomography Computed Tomography
4
Magnetic Resonance Imaging
4
Lenalidomide
4
Biopsy, Fine-Needle
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surgical Procedures, Operative
3
Melphalan
3
Liquid Biopsy
3
Interviews as Topic
3
Exercise
3
Diagnostic Tests, Routine
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Urination
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Diagnosis
×
Clear all
NCT03645018
2018-09-14
SOS2
Ospedale Santa Croce-Carle Cuneo
Phase 3
Completed
1,341 enrolled